Patrick Ma, M.D., recently spoke at the World Non-Small-Cell Lung Cancer (NSCLC) Summit in Boston, with a presentation titled, "MET Targeted Therapy in NSCLC." Dr. Ma is the co-leader of the Sara Crile Allen and James Frederick Allen Comprehensive Lung Cancer Program at the Mary Babb Randolph Cancer Center,
The Allen Lung Cancer Program will also have a major presence at the 16th World Conference on Lung Cancer Sept. 6-9 in Denver. Several abstracts submitted by the program have been accepted for presentation.
Ma will make two major oral presentations and two mini oral presentations.
- The title of the major oral presentations are "Whole Exome Sequencing to Profile the Genomic Landscapes of Young Patients Diagnosed with NSCLC." WVU co-authors include Xiaoliang Wu, Wei Zhang and Scot Remick, M.D.
- The title of the second major oral presentation is "ALK-Rearranged NSCLC Adaptive Cell Plasticity with Early Onset TGFb2 Mediated Precision Drug Escape through PRC-2 Epigenetic Reprogramming." WVU co-authors include Wu and Zhang.
- One of the mini oral presentations is titled "Transcriptome-Metabolome Reprogramming of EGFR-Mutant NSCLC Contributes to Early Adaptive Drug-Escape via BCL-xL Mitochondrial Priming." WVU co-authors are Wu and Zhang.
- The second mini oral presentation is titled "Circulating Tumor Cells (CTC) Enrichment as Liquid-Biopsy for Molecular and Genomic Characterization in ALK-Rearranged (ALK+) Lung Cancer." WVU co-author is Zhang.
The program will also present a poster titled "Quantitative Immunofluorescence Based Expression Analysis in NSCLC Reveals Nuclear EZH2 as Poor Prognostic Biomarker." WVU authors include Sijin Wen, Ph.D., Zhang and Ma.
In addition, hematology oncology fellow graduate Abdul Rahman Alshehri, M.D., will make a mini oral presentation titled "Quantitative Mass Spectrometry Proteomics Identifies FRalpha and GARFT as Predictive Biomarkers in NSCLC Patients Treated With Pemetrexed." WVU’s Manish Monga, M.D., is last author, and Ma is co-author.
The World Conference on Lung Cancer is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies.
The WVU Cancer Institute lung cancer support group team in conjunction with the Lung Cancer Alliance will host the first annual Shine a Light on Lung Cancer in observance of lung cancer awareness month on November 28, 2017 from 5 to 6 p.m. in the ground floor conference room at the Mary Babb Randolph Cancer Center. This is an event for current and past patients and their families to provide education about lung cancer and new treatment updates, and will be an opportunity to honor those living with lung cancer and those we have lost to the disease. Several members of the lung cancer team will share recent clinical advances and memorable patient experiences. Please contact Adrienne Duckworth, NP, or Rachel Harper, MSW, or call 304-598-4500, if you plan to attend. Light refreshments will be provided. All Cancer Institute staff are welcome.
WVU Cancer Institute’s Cancer Prevention and Control has expanded its Bridge Program that focuses on lung cancer survivorship to United Hospital Center (UHC) in Bridgeport. The goal of the Cancer Institute and UHC’s Bridge Program is to improve the coordination of care and decrease the consequences of treatment for patients diagnosed with stage I, II, or III lung cancer after they complete treatment.
The fourth annual Pink Party to benefit the Bonnie Wells Wilson Mobile Mammography Program (Bonnie’s Bus) was a huge success. Nearly 200 attendees, wearing their favorite shades of pink, enjoyed a special evening at Touchdown Terrace at Milan Puskar Stadium on November 13 to support one of their favorite causes – Bonnie’s Bus. “Thank you for being so supportive,” Jo Statler told the crowd. “Because you are here, that tells me you have big hearts.” She and her husband Ben made a generous gift to the WVU Cancer Institute eight years ago to establish the mobile mammography program, named after Jo’s late mother, Bonnie Wells Wilson.